111

111 EBITDA per Employee

The EBITDA per Employee of 111 (YI) as of Nov 1, 2026 is -69,639.78 CNY. In the previous year, EBITDA per Employee was 14,680.56 CNY — a change of -574.37% (lower).

EBITDA per Employee

-69,639.78CNY

YoY

-574.37%

Last updated:

EBITDA per Employee of 111 is 2025 -69,639.78 CNY. EBITDA per Employee of 111 was 2024 14,680.56 CNY. It decreases by -574.37% lower compared to the previous year.

The 111 EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2018
-2.78 M CNY
Jan 1, 2019
-3.43 M CNY
Jan 1, 2020
-3.29 M CNY
Jan 1, 2021
-4.46 M CNY
Jan 1, 2022
-2.52 M CNY
Jan 1, 2023
-2.31 M CNY
Jan 1, 2024
14,680.56 CNY
Jan 1, 2025
-69,639.78 CNY
The 111 EBITDA per Employee history
YEAREBITDA per EmployeeYoY
-69,639.78CNY-574.37%
14,680.56CNY-100.63%
-2.31 MCNY-8.16%
-2.52 MCNY-43.53%
-4.46 MCNY+35.67%
-3.29 MCNY-4.09%
-3.43 MCNY+23.26%
-2.78 MCNY+57.61%
-1.76 MCNY-30.27%
-2.53 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

111 Stock analysis

What does 111 do? 111 Inc, trading under the ticker YI and ISIN US68247Q2012, is a company based in Shanghai, China, operating within the Consumer Staples sector and Retail industry. The company went public on September 12, 2018. According to the provided information, 111 Inc is engaged in the provision of pharmaceutical products and medical services through online retail pharmacy and an indirect offline pharmacy network. The company's website is http://gangling.111.com.cn/. The employee count provided in the user message is 144, though the source description mentions 1,932 full-time employees, which is inconsistent. The company focuses on online medical services, drug purchasing, and health management services utilizing internet and information technology. It primarily serves the domestic market in China. The company's headquarters are located in Shanghai, Shanghai, and it operates with a focus on retail and consumer staples within the pharmaceutical and healthcare services domain. 111 is one of the most popular companies on Eulerpool.

Frequently Asked Questions about 111 stock

EBITDA per Employee of 111 is -69,639.78 CNY in 2025.

EBITDA per Employee of 111 changed from 14,680.56 CNY to -69,639.78 CNY, representing a -574.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee 111 since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's 111 historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — 111

All Key Metrics — 111